Clinical Trial

Comparison of Outcomes of Right Internal Jugular Port Implantation in Patients With Right Versus Left Breast Cancer Undergoing Chemotherapy

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 29, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
Chemotherapy is an essential component of breast cancer treatment. Frequent intravenous injections may lead to phlebitis and limited venous access, therefore implantable venous ports are increasingly used. The choice of port placement side in breast cancer patients is controversial, especially when mastectomy or radiotherapy is planned. This retrospective cohort study compares one-year patency, complications (infection, thrombosis, skin necrosis), and functional outcomes of ports implanted via the right internal jugular vein in patients with right versus left breast cancer.
Trial Details
NCT Number NCT07197320
Lead Sponsor Golestan University of Medical sciences
Conditions Port-A-Cath
Enrollment 80 participants
Start Date 2025-11
Primary Completion 2026-02 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2025-09-29